Skip to main content
iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
2.500
-0.110 (-4.21%)
At close: Mar 9, 2026, 4:00 PM EDT
2.540
+0.040 (1.60%)
After-hours: Mar 9, 2026, 5:54 PM EDT

iBio, Inc. Revenue

iBio, Inc. had revenue of $300.00K in the twelve months ending December 31, 2025, down -20.00% year-over-year. In the fiscal year ending June 30, 2025, iBio, Inc. had annual revenue of $400.00K with 77.78% growth.

Revenue (ttm)
$300.00K
Revenue Growth
-20.00%
P/S Ratio
280.95
Revenue / Employee
$15,000
Employees
20
Market Cap
86.36M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2025400.00K175.00K77.78%
Jun 30, 2024225.00K--
Jun 30, 2023---
Jun 30, 20221.88M-487.00K-20.54%
Jun 30, 20212.37M733.00K44.75%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Champions Oncology 58.42M
Pelthos Therapeutics 7.41M
Pyxis Oncology 2.82M
Kazia Therapeutics 1.20M
Seres Therapeutics 351.00K
aTyr Pharma 190.00K
Revenue Rankings

IBIO News

More News